Munch-a-Biotech Today Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (246)	3/5/1999 12:42:00 PM
From: LLCF	Read Replies (1) of 3158

< However, they've always been accused of having too diffuse a focus, with more interest in science than product,> Yes, this is mentioned in the report... as is the "dillution" factor (states they doubt they would do anything diluting a couple years out). Here's more: "External opportunities will likely come int he form of Phase1 or 11 product and/or company aquisitions, since companies with successful high growth products are generally trading at valuations beyond Chiron's means. Meanwhile, the industry's many earlier stage opportunities are trading at relatively low valuations and represent a good opportunity for a Chiron shopping spree." Sounds like this guy has been reading this thread at nite... sneaky guy! Wonder if Mr. Chiron needs a lift over to the "bio-mall" for his "shopping spree" nyuk, nyuk. DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next